“There is also some speculative activity in the October $20 strike puts as some believe that the bad news on Questcor is not over and that the stock could suffer more losses in the near term.” Overall option volume on Questcor saw 31,000 …
Questcor Pharmaceuticals, Inc. (QCOR) was a big mover last session, as the company saw its shares shoot up nearly 19% on the day. This surge can be attributable to solid volume with far more shares changing hands than in a normal …
ANAHEIM — Mallinckrodt is buying Anaheim-based Questcor Pharmaceuticals Inc. for a combination of stock and cash valued at about $5.2 billion. Mallinckrodt makes a range of specialty pharmaceuticals. Questcor's primary product is …
QCOR), the price of which surged +17.73%. The company is being purchased by Mallinckrodt (NYSE:MNK) for $5.2 billion in cash and stock. Questcor and Mallinckrodt are part of John Paulson’s portfolio. Second comes Idenix …
The top after-market NASDAQ stock market losers are: Biostar Pharmaceuticals, Coleman Cable, China Sunergy, Questcor Pharmaceuticals, and FSI International. LJ International Inc. (JADE) surged 9.40 percent to $5.70 in the after …
Questcor and the charity have said they are victims of a campaign by short-sellers - investors who benefit from the decline of a stock’s price. Nonetheless, fearing defections from donors, the charity hired Venable, a law firm in Washington, to …
The list screens for inexpensive stocks that are outside of consensus favor and stock ideas that use the Merrill Lynch ...
Irish pharmaceutical company Mallinckrodt will pay $5.6 billion in cash and stock for Anaheim-based Questcor Pharmaceuticals Inc., a fast-growing bio-pharmaceutical firm that specializes in treating multiple sclerosis, the …
Most analysts tracking Questcor Pharmaceuticals are still rating it a buy, despite the stock diving nearly 50% on Wednesday over concerns that insurance companies were moving to limit coverage of the company’s primary revenue …
Mallinckrodt is buying California-based Questcor Pharmaceuticals Inc. for a combination of stock and cash valued at about $5.6 billion that will help to further diversify the Irish company's business. Mallinckrodt makes a range of specialty …